🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Squamous Cell Carcinoma of the Skin

Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma NCT06606028n/a1 site📍 San Francisco University of California, San Francisco · Tests: Blood Specimen Collection, Tumor Tissue Collection, Medical Record Review A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma NCT06567314Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Ivonescimab Study of GV20-0251 in Participants With Solid Tumor Malignancies NCT07070518Phase 1, Phase 23 sites📍 Beijing📍 Beijing📍 Shanghai GV20 Therapeutics · Tests: GV20-0251 A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors NCT06700070EARLY Phase 11 site📍 Shreveport Pure Biologics S.A. · Tests: PBA-0111 Towards Cure Via Only Ultra-short ICB in CSCC NCT06823479Phase 25 sites📍 Maastricht📍 Amsterdam📍 Amsterdam The Netherlands Cancer Institute · Tests: Nivolumab, Ipilumimab A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites📍 Grand Rapids📍 St Louis📍 Pittsburgh AstraZeneca · Tests: AZD6750, rilvegostomig Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors NCT07628634EARLY Phase 11 site📍 Orange University of California, Irvine · Tests: Methionine-Reduced Diet TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer NCT06868433Phase 12 sites📍 Atlanta📍 Atlanta Emory University · Tests: Autologous Tumor Membrane Vesicles Vaccine, Biospecimen Collection, Computed Tomography, Echocardiography, Magnetic Res… Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy NCT07426484Phase 42 sites📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: Cosibelimab, Prednisone, Sirolimus, Everolimus Clinical Study of CFH Protein Via Ice Microneedles for Radiation-Induced Skin Fibrosis NCT07567235Phase 11 site📍 Chengdu West China Hospital · Tests: CFH Protein-loaded Ice Microneedles (0.5 mg), CFH Protein-loaded Ice Microneedles (1.0 mg), CFH Protein-loaded Ice Micr… A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies NCT05669430Phase 1, Phase 213 sites📍 Los Angeles📍 Denver📍 New Haven GV20 Therapeutics · Tests: GV20-0251, GV20-0251, GV20-0251 and Pembrolizumab [KEYTRUDA®], GV20-0251 and Pembrolizumab [KEYTRUDA®] Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System NCT07042295Phase 255 sites📍 Birmingham📍 Gilbert📍 La Jolla National Cancer Institute (NCI) · Tests: Amivantamab and Recombinant Human Hyaluronidase, Biospecimen Collection, Cetuximab, Computed Tomography, Magnetic Reson… SUV PDL1/PD1 in Sun Damaged & Sun Protected Human Skin of Participants NCT06177106NA1 site📍 Tucson University of Arizona · Tests: Solar Simulated Light Skin Cancer and Hyperthermia and Radiotherapy NCT06384053NA4 sites📍 Aarau📍 Winterthur📍 Bern Kantonsspital Winterthur KSW · Tests: Water-filtered infrared-A-hyperthermia (wIRA) hyperthermia combined, Radiotherapy (RT) TIL Therapy in cSCC and MCC NCT07288073Phase 21 site📍 Boston Karam Khaddour, MD, MS · Tests: LN-145, Cyclophosphamide, Fludarabine, Interleukin-2 Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies NCT07682831NA1 site📍 Victor University of Rochester · Tests: Two photon microscopy imaging PET-imaging of Two Vartumabs in Patients With Solid Tumors NCT06645808EARLY Phase 11 site📍 Groningen Var2 Pharmaceuticals · Tests: 89Zr-DFO-N-Suc-F8scFv, 89Zr-DFO-N-Suc-C9scFv, PET/CT scan A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors NCT07600476Phase 13 sites📍 Munich📍 Würzburg📍 Münster Kupando GmbH · Tests: KUP-101A A Study of DB-1310 in Advanced/Metastatic Solid Tumors NCT05785741Phase 1, Phase 224 sites📍 Sacramento📍 Santa Monica📍 Coral Gables DualityBio Inc. · Tests: DB-1310, Trastuzumab, Osimertinib, capecitabine Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC NCT05047094NA3 sites📍 Jerusalem📍 Ramat Gan📍 Tel Aviv Alpha Tau Medical LTD. · Tests: Diffusing Alpha Radiation Emitters Therapy (DaRT), Pembrolizumab L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma NCT07228442Phase 219 sites📍 Orange📍 Atlanta📍 Boston Philogen S.p.A. · Tests: L19IL2/L19TNF A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression NCT06682793Phase 1, Phase 210 sites📍 Gilbert📍 La Jolla📍 Los Angeles A2 Biotherapeutics Inc. · Tests: A2B395, xT CDx with HLA-LOH assay MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors NCT05076760Phase 12 sites📍 Tampa📍 Durham Memgen, Inc. · Tests: MEM-288 Intratumoral Injection, Nivolumab, Docetaxel (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma NCT05747625Phase 11 site📍 Nashville Eben Rosenthal · Tests: Panitumumab, Zirconium Zr 89 Panitumumab, Positron Emission Tomography, Computed Tomography, Electronic Health Record R… Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma NCT06288191Phase 21 site📍 Wollstonecraft Melanoma Institute Australia · Tests: Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination A Study of SH009 Injection in Patients With Advanced Solid Tumors. NCT07390838Phase 11 site📍 Shanghai Nanjing Sanhome Pharmaceutical, Co., Ltd. · Tests: SH009 Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Home Health Encounter, Nivolumab, Patient Monitoring, Questionnaire Administration Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer NCT05896839Phase 1, Phase 226 sites📍 La Jolla📍 Los Angeles📍 Los Angeles National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Kidney Biopsy Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC) NCT05377905Phase 1, Phase 21 site📍 Pittsburgh Falo, Louis, MD · Tests: Microneedle Array Doxorubicin (MNA-D)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy